Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

LeukArrest progresses in clinical trials for stroke

Jan. 27, 1999

Ligand inhibitors of CRF/CRF-binding protein complex reported by Lilly

Jan. 27, 1999

Neuronal Ca2+ channel-blocking peptides in development at Mitsubishi

Jan. 27, 1999

New amidines synthesized at Astra are selective inhibitors of nNOS

Jan. 27, 1999

Pharmacia & Upjohn's antiparkinsonian approved in Spain

Jan. 26, 1999

BTG enters agreement with Novo Nordisk for pain and epilepsy compounds

Jan. 26, 1999

More 5-HT4 receptor ligands in development at Synthelabo

Jan. 26, 1999

Subunit-selective GABA-A receptor ligands for anxiety, convulsions reported by MS&D

Jan. 26, 1999

L-754030 will enter phase III testing for emesis

Jan. 25, 1999

Preparation and use of neuronal NOS inhibitors disclosed by Astra

Jan. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...